Encompass Health Co. (NYSE:EHC) Position Lessened by Leeward Investments LLC MA

Leeward Investments LLC MA trimmed its holdings in shares of Encompass Health Co. (NYSE:EHC) by 11.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 450,874 shares of the company’s stock after selling 56,539 shares during the quarter. Encompass Health accounts for about 2.1% of Leeward Investments LLC MA’s investment portfolio, making the stock its biggest position. Leeward Investments LLC MA’s holdings in Encompass Health were worth $41,638,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. CIBC Asset Management Inc increased its holdings in Encompass Health by 3.5% in the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock valued at $286,000 after buying an additional 100 shares during the last quarter. Miracle Mile Advisors LLC increased its holdings in Encompass Health by 3.0% in the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after buying an additional 112 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its holdings in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after buying an additional 137 shares during the last quarter. Verdence Capital Advisors LLC increased its holdings in Encompass Health by 4.6% in the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock valued at $355,000 after buying an additional 160 shares during the last quarter. Finally, V Square Quantitative Management LLC increased its holdings in Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after buying an additional 177 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently weighed in on EHC shares. Truist Financial reissued a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Barclays lifted their target price on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. Royal Bank of Canada restated an “outperform” rating and issued a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. KeyCorp lifted their target price on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Finally, StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and an average price target of $107.67.

Insiders Place Their Bets

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.10% of the stock is currently owned by insiders.

Encompass Health Stock Performance

EHC opened at $97.42 on Friday. The company has a market capitalization of $9.81 billion, a price-to-earnings ratio of 21.84, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 1-year low of $73.68 and a 1-year high of $104.55. The business has a 50 day moving average price of $95.98 and a two-hundred day moving average price of $95.89.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Research analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.70%. Encompass Health’s dividend payout ratio (DPR) is 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.